AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
30 hedge funds and large institutions have $331M invested in Ambrx Biopharma Inc in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
67% more funds holding
Funds holding: 18 → 30 (+12)
Holders
30
Holding in Top 10
4
Calls
$13.1M
Puts
$2.3M
Top Buyers
| 1 | +$55M | |
| 2 | +$42.8M | |
| 3 | +$35.1M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$33.2M |
| 5 |
VA
VR Adviser
New York
|
+$29.4M |
Top Sellers
| 1 | -$15M | |
| 2 | -$12.9M | |
| 3 | -$4.33M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.33M |
| 5 |
AGM
Alpine Global Management
New York
|
-$106K |